Chemclin Diagnostics Co. Ltd. A (688468) - Total Liabilities

Latest as of March 2026: CN¥344.10 Million CNY ≈ $50.35 Million USD

Based on the latest financial reports, Chemclin Diagnostics Co. Ltd. A (688468) has total liabilities worth CN¥344.10 Million CNY (≈ $50.35 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Chemclin Diagnostics Co. Ltd. A - Total Liabilities Trend (2017–2025)

This chart illustrates how Chemclin Diagnostics Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See Chemclin Diagnostics Co. Ltd. A short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Chemclin Diagnostics Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Chemclin Diagnostics Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
TSS, Inc. Common Stock NASDAQ:TSSI	USA	$74.90 Million
Bakkt Holdings Inc NYSE:BKKT	USA	$42.50 Million
HPF Co Ltd SHE:300350	China	CN¥412.59 Million
Alantra Partners S.A. MC:ALNT	Spain	€101.40 Million
Zhejiang Shengda Pharm SHG:603079	China	CN¥561.97 Million
Hangzhou Coco Healthcare Products Co.Ltd. SHE:301009	China	CN¥739.23 Million
The Star Entertainment Group Limited F:EE9	Germany	€1.07 Billion
Semler Scientific Inc NASDAQ:SMLR	USA	$136.93 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Chemclin Diagnostics Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688468 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.24	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chemclin Diagnostics Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chemclin Diagnostics Co. Ltd. A (2017–2025)

The table below shows the annual total liabilities of Chemclin Diagnostics Co. Ltd. A from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥350.05 Million ≈ $51.22 Million	-15.82%
2024-12-31	CN¥415.85 Million ≈ $60.85 Million	-3.68%
2023-12-31	CN¥431.76 Million ≈ $63.18 Million	+105.02%
2022-12-31	CN¥210.59 Million ≈ $30.82 Million	+38.33%
2021-12-31	CN¥152.23 Million ≈ $22.28 Million	+27.43%
2020-12-31	CN¥119.46 Million ≈ $17.48 Million	-5.50%
2019-12-31	CN¥126.42 Million ≈ $18.50 Million	+56.33%
2018-12-31	CN¥80.87 Million ≈ $11.83 Million	+22.24%
2017-12-31	CN¥66.15 Million ≈ $9.68 Million	--

About Chemclin Diagnostics Co. Ltd. A

SHG:688468 China Diagnostics & Research

Market Cap

$348.65 Million

CN¥2.38 Billion CNY

Market Cap Rank

#14219 Global

#4261 in China

Share Price

CN¥5.94

Change (1 day)

-1.66%

52-Week Range

CN¥5.94 - CN¥8.94

All Time High

CN¥27.99